Seeing Is Believing
Currently out of the existing stock ratings of Leland Gershell, 186 are a BUY (92.54%), 6 are a SELL (2.99%), 9 are a HOLD (4.48%).
Analyst Leland Gershell, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 33.15% that have a potential upside of 37.12% achieved within 139 days.
Leland Gershell’s has documented 424 price targets and ratings displayed on 47 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ASND, Ascendis Pharma AS at 13-Jun-2025.
Analyst best performing recommendations are on CAPR (CAPRICOR THERAPEUTICS).
The best stock recommendation documented was for CAPR (CAPRICOR THERAPEUTICS) at 9/23/2024. The price target of $15 was fulfilled within 7 days with a profit of $9.03 (151.26%) receiving and performance score of 216.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$12
$8.63 (256.08%)
$12
8 months 30 days ago
(26-Sep-2024)
0/2 (0%)
$8.93 (290.88%)
Buy
$2.5
$-0.28 (-10.07%)
2 years 4 months 11 days ago
(15-Feb-2023)
1/1 (100%)
$1.86 (290.63%)
145
Buy
$30
3 years 3 days ago
(22-Jun-2022)
0/2 (0%)
$22.32 (290.63%)
Buy
4 years 9 months 25 days ago
(31-Aug-2020)
0/1 (0%)
$59.52 (163.16%)
Which stock is Leland Gershell is most bullish on?
Which stock is Leland Gershell is most reserved on?
What Year was the first public recommendation made by Leland Gershell?